From bench to bedside – A mission for a healthy life
From bench to bedside – A mission for a healthy life
The DRFZ investigates the long‐term outcomes of rheumatic diseases, including the impact of current treatment options, in order to inform clinical decision making, identify unmet needs and improve health care. Biomedical research identifies the cells initiating and those driving rheumatic diseases, and the underlying molecular mechanisms. Our aim is the development of improved, personalised, at best curative therapies for patients with rheumatic diseases, and their rapid translation into clinical practice.
News
Science at DRFZ
Gi-Ung Kang: MicroBiotR: A comprehensive all-in-one pipeline for deep mining analysis of microbiota flow cytometry and next generation sequencing
Maria Dzamukova: The role of macrophage metabolism in age-associated diseases
Caroline Tizian: MicroRNAs confer transcriptional stability to innate lymphoid cells
Andrey Kruglov: Regulation of chronic inflammation by microbiota
Mediathek
![Mir-Farzin Mashregi](https://www.drfz.de/wp-content/uploads/mashregi-labor-550x309.jpg)
News | 21.November 2022
Mir-Farzin Mashreghi
...... is the new head of the Systems Rheumatology Research Department
![Strangfeld](https://www.drfz.de/wp-content/uploads/strangfeld-4-550x309.jpg)
News | 10. March 2022
Anja Strangfeld
... is the head of the Programme Area Epidemiology at the DRFZ
![Carsten Watzl](https://www.drfz.de/wp-content/uploads/watzl-550x309.jpg)
News | 02. November 2022
Carsten Watzl
... has been Chairman of the Scientific Advisory Board of the DRFZ since September 2022